HMPUBLISHERHMPUBLISHER

Community Medicine and Education JournalCommunity Medicine and Education Journal

Hyperuricemia management relies heavily on synthetic xanthine oxidase inhibitors, which possess adverse effect risks. This pilot trial evaluates the short-term clinical effects of a standardized Syzygium polyanthum (Indonesian bay leaf) tea infusion on serum uric acid levels in a primary care setting, standardizing conventional preparation methods. A quasi-experimental, pre- and post-test controlled pilot trial was conducted at a community health center on Sumatra Island, Indonesia. Twenty-four adults with hyperuricemia were purposively assigned (alternating days of presentation) to an intervention group (n=12) or a control group (n=12). The intervention comprised 2.0 grams of standardized S. polyanthum tea infused at 80 degrees Celsius for 1 to 3 minutes, consumed twice daily for seven days. Both groups underwent monitored dietary purine restriction. Serum uric acid was evaluated via capillary analysis. The intervention cohort exhibited a statistically significant reduction in median serum uric acid from 8.1 mg/dL (Interquartile Range [IQR]: 7.4–8.9) to 6.9 mg/dL (IQR: 6.2–7.5) (p=0.034). The control group showed no significant alteration (median 8.0 mg/dL to 7.9 mg/dL; p=0.299). Intervention compliance was 95.4%, with no adverse gastrointestinal events reported. In conclusion, standardized S. polyanthum tea infusion significantly reduces serum uric acid over seven days, presenting a culturally syntonic and safe complementary intervention for primary healthcare frameworks, though extended treatment may be required to reach optimal clinical targets below 6.0 mg/dL.

This pilot study demonstrates that a standardized 2.0-gram Syzygium polyanthum tea infusion, administered twice daily, effectively lowers serum uric acid levels in hyperuricemic adults over a seven-day period.The intervention operates through a combination of hepatic xanthine oxidase inhibition and enhanced renal diuresis.While the results are promising, longer treatment durations are necessary to achieve and maintain serum uric acid levels consistently below the 6.0 mg/dL threshold for optimal clinical outcomes.

Future research should investigate the optimal duration of Syzygium polyanthum tea infusion treatment to achieve sustained serum uric acid control below 6.0 mg/dL, considering individual patient characteristics and metabolic profiles. Further studies are needed to explore the specific mechanisms underlying the observed diuretic effects of S. polyanthum, potentially focusing on the role of essential oils and their impact on renal hemodynamics. Finally, large-scale, randomized controlled trials are crucial to confirm the long-term safety and efficacy of standardized S. polyanthum tea infusion as a complementary therapy for hyperuricemia, and to assess its potential integration into primary healthcare systems, particularly in regions where the plant is culturally significant and readily available. These investigations should also explore the potential synergistic effects of combining S. polyanthum with dietary modifications and other lifestyle interventions to optimize patient outcomes and reduce the reliance on synthetic medications.

  1. Short-Term Clinical Effects of Standardized Syzygium polyanthum (Bay Leaf) Tea Infusion on Serum Uric... hmpublisher.com/index.php/CMEJ/article/view/873Short Term Clinical Effects of Standardized Syzygium polyanthum Bay Leaf Tea Infusion on Serum Uric hmpublisher index php CMEJ article view 873
Read online
File size1.17 MB
Pages14
DMCAReport

Related /

ads-block-test